首页 | 本学科首页   官方微博 | 高级检索  
     

肿瘤坏死因子基因多态性与多发性骨髓瘤的临床相关关系
引用本文:赵洪云,陈运贤,钟雪云,黄颖强. 肿瘤坏死因子基因多态性与多发性骨髓瘤的临床相关关系[J]. 肿瘤防治研究, 2005, 32(12): 764-767
作者姓名:赵洪云  陈运贤  钟雪云  黄颖强
作者单位:1. 510060,广州,华南肿瘤学国家重点实验室;中山大学肿瘤防治中心内科
2. 中山大学第一附属医院血液内科
3. 暨南大学医学院
4. 暨南大学信息科学技术学院数学系
摘    要: 目的 探讨肿瘤坏死因子α(Tumor necrosis factor alpha,TNFα)基因-308位和淋巴毒素(Lymphotoxin-α,LTα)基因+252住基因多态性与多发性骨髓瘤(Multiple Myeloma,MM)发病、临床及预后的相关关系。方法 用聚合酶链反应(PCR)、限制性内切酶消化及电泳技术,对32名MM患者和72名正常对照者的TNFα和LTα基N的单碱基突变多态性进行检测,并收集病人组的临床资料,进行生存状况分析。结果 (1)MM病人TNF两位点基因型频率、等住基因频率、联合单倍体分型中各型的频率与对照组比较差异均无统计学意义(P〉0.05);(2)比较MM病人两位点联合单倍体分型在不同性别、分期、肿瘤负荷、血红蛋白、血钙、血肌酐中的分布,没有发现显著性差异(P〉0.05);(3)用KaplanMeier方法进行生存分析,没有发现高危型与低危型的总生存时间有显著性差异:在高危型组和低危型组,2年生存率和4年生存率差异无统计学意义(P〉0.05);Cox回归模型显示两位点联合单倍体分型不是影响预后的危险因素(P〉0.05)。结论 本组研究显示TNFα-308位、LTα+252住基因多态性在MM病人发病的易感性、临床和预后中可能不起重要作用。

关 键 词:多发性骨髓瘤  肿瘤坏死因子  基因多态性
文章编号:1000-8578(2005)12-0764-04
收稿时间:2005-04-28
修稿时间:2005-04-282005-09-26

Clinical Relationship between Tumor Necrosis Factor Genetic Polymorphisms and Multiple Myeloma
ZHAO Hong-yun,CHEN Yun-xian,ZHONG Xue-yun,HUANG Ying-qiang. Clinical Relationship between Tumor Necrosis Factor Genetic Polymorphisms and Multiple Myeloma[J]. Cancer Research on Prevention and Treatment, 2005, 32(12): 764-767
Authors:ZHAO Hong-yun  CHEN Yun-xian  ZHONG Xue-yun  HUANG Ying-qiang
Affiliation:1. State Key Laboratory of Onocology in Southern China , Guangzhou 510060 , China;2. Department of Medical Oncology , Cancer Center , Sun Yat-Sen University ; 3. Department of Hematology , The First Affiliated Hospital of Sun Yat-sen University ; 4. Medical College of Ji′nan University ; 5. Department of Mathematics , Ji′nan University
Abstract:Objective  This study was designed to investigate the relationship between-308bp polymorphism in tumor necrosis factor-α( TNFα) gene and + 252bp in lymphotoxin-α(L Tα) gene and the pathogenesis ,clinical course and outcome of multiple myeloma (MM) . Methods  The single base change polymorphism in TNFα gene and L Tα gene were analyzed among 32 chinese patient s with MM and 72 normal controls by using PCR-rest rictive f ragment length polymorphism ( RFL P) . The clinical data were collected andsurvival analysis was performed. Results  (1) The difference of dist ribution of genotypes ,alleles of TNFα ( 3/ 308) , L Tα( + 252) and TNF/ L T polymorphic extended haplotypes between the MM patients and control group were not statistically significant ( P > 0. 05) . (2) In patients group , no statistically significant association was found between the presence of a given TNF/ L T haplotype status and clinical characters such as sex , age , clinical stags ,myeloma burthen , hemoglobin , creatinine. (3) The estimated 22year and 42year overall survival rates in the groups of patient s carrying high-risk and low-risk haplotypes were not statistically significant ( P > 0. 05) using Kaplan-Meier method. In multivariate Cox regression models the TNF/L T haplotype status was not found to be risk factors for outcome ( P > 0. 05) . Conclusion  These data suggest that genetic polymorphisms in the TNFα( 3/308) ,L Tα( + 252) are not crucial in the pathogenesis ,clinical course ,outcome of MM patients.
Keywords:Multiple myeloma   Tumor necrosis factor   Gene polymorphism
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号